Taigen Biopharmaceuticals Holdings Ltd (4157) — Financial Flexibility Index
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Financial Flexibility Index of -0.52x as of September 2025. Free cash flow of NT$-62.27 Million (operating CF NT$-62.73 Million minus capex NT$465.00K) represents -1% of total liabilities (NT$120.70 Million). Also explore Taigen Biopharmaceuticals Holdings Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Taigen Biopharmaceuticals Holdings Ltd Financial Flexibility Index (2010–2024)
Historical Financial Flexibility Index trend for Taigen Biopharmaceuticals Holdings Ltd across 15 annual periods. Check 4157 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Taigen Biopharmaceuticals Holdings Ltd (2010–2024)
Year-by-year free cash flow to debt coverage for Taigen Biopharmaceuticals Holdings Ltd. For the full company profile including market capitalisation, see 4157 market cap overview.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.85x | NT$-170.39 Million | NT$-173.09 Million | NT$91.96 Million | ▼ -830.7% |
| 2023 | 0.25x | NT$28.14 Million | NT$20.74 Million | NT$110.94 Million | ▲ +241.4% |
| 2022 | -0.18x | NT$-13.80 Million | NT$-21.27 Million | NT$76.98 Million | ▼ -103.9% |
| 2021 | 4.61x | NT$640.90 Million | NT$629.07 Million | NT$139.11 Million | ▲ +325.3% |
| 2020 | -2.05x | NT$-233.69 Million | NT$-242.10 Million | NT$114.26 Million | ▲ +20.7% |
| 2019 | -2.58x | NT$-337.46 Million | NT$-342.52 Million | NT$130.92 Million | ▼ -4.8% |
| 2018 | -2.46x | NT$-231.96 Million | NT$-254.93 Million | NT$94.36 Million | ▲ +3.5% |
| 2017 | -2.55x | NT$-248.84 Million | NT$-266.93 Million | NT$97.71 Million | ▼ -164.8% |
| 2016 | -0.96x | NT$-142.16 Million | NT$-152.83 Million | NT$147.82 Million | ▲ +69.4% |
| 2015 | -3.14x | NT$-577.23 Million | NT$-592.56 Million | NT$183.86 Million | ▼ -46.1% |
| 2014 | -2.15x | NT$-528.73 Million | NT$-540.03 Million | NT$246.05 Million | ▼ -59.7% |
| 2013 | -1.35x | NT$-447.59 Million | NT$-458.46 Million | NT$332.71 Million | ▼ -265.5% |
| 2012 | -0.37x | NT$-132.93 Million | NT$-141.36 Million | NT$361.15 Million | ▲ +90.3% |
| 2011 | -3.79x | NT$-369.00 Million | NT$-379.23 Million | NT$97.31 Million | ▼ -10993.8% |
| 2010 | -0.03x | NT$-184.65 Million | NT$-196.43 Million | NT$5.40 Billion | — |